HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 10 of 10
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Sugiura, Ryo; Nakamura, Hideaki; Horita, Shoichi; Meguro, Takashi; Sasaki, Kiyotaka; Kagaya, Hidetoshi; Yoshida, Tatsuya; Aoki, Hironori; Morita, Takayuki; Fujita, Miyoshi; Tamoto, Eiji; Fukushima, Masayuki; Ashitate, Yoshitomo; Ueno, Takashi; Tsutaho, Akio; Kuwatani, Masaki; Sakamoto, NaoyaAssessment of postoperative common bile duct stones after endoscopic extraction and subsequent cholecystectomy-Surgical endoscopy and other interventional techniques-1-Sep-2022
articleSho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, NaoyaEarly response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting-JGH open-Feb-2020
articleSho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, NaoyaEfficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150-Cancers-15-Aug-2022
article (author version)Chuma, Makoto; Hige, Shuhei; Kamiyama, Toshiya; Meguro, Takashi; Nagasaka, Atsushi; Nakanishi, Kazuaki; Yamamoto, Yoshiya; Nakanishi, Mitsuru; Kohara, Toshihisa; Sho, Takuya; Yamamoto, Keiko; Horimoto, Hiromasa; Kobayashi, Tomoe; Yokoo, Hideki; Matsushita, Michiaki; Todo, Satoru; Asaka, MasahiroThe influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma-Journal of Gastroenterology-Sep-2009
articleHosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, NaoyaLow baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment-Liver Cancer-Jun-2023
articleSho, Takuya; Nakanishi, Mitsuru; Morikawa, Kenichi; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Nakai, Masato; Suda, Goki; Ogawa, Koji; Chuma, Makoto; Meguro, Takashi; Nakamura, Michio; Nagasaka, Atsushi; Horimoto, Hiromasa; Yamamoto, Yoshiya; Sakamoto, NaoyaA Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma-Drugs in R&D-Sep-2017
article (author version)Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, Hiroshi; Kobayashi, Yoshimitsu; Iwanaga, Ichiro; Nakamura, Michio; Hatanaka, Kazuteru; Miyagishima, Takuto; Kudo, Mineo; Munakata, Masaki; Meguro, Takashi; Tateyama, Miki; Sakata, YuhPhase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer-Acta Oncologica-Sep-2012
articleYasuyuki, Kawamoto; Satoshi, Yuki; Kentaro, Sawada; Tsuji, Yasushi; Dazai, Masayoshi; Okuda, Hiroyuki; Meguro, Takashi; Harada, Kazuaki; Sekiguchi, Mari; Okada, Kazufumi; Ito, Yoichi M.; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoPhase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer : HGCSG1603-The Oncologist-Aug-2022
articleNakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, YuStudy protocol for HGCSG1801 : A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies-Frontiers in oncology-9-Nov-2022
articleOgawa, Koji; Kobayashi, Takashi; Furukawa, Jun-ichi; Hanamatsu, Hisatoshi; Nakamura, Akihisa; Suzuki, Kazuharu; Kawagishi, Naoki; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Baba, Masaru; Furuya, Ken; Terashita, Katsumi; Kobayashi, Tomoe; Onodera, Manabu; Horimoto, Takahiro; Shinada, Keisuke; Tsunematsu, Seiji; Tsunematsu, Izumi; Meguro, Takashi; Mitsuhashi, Tomoko; Hato, Megumi; Higashino, Kenichi; Shinohara, Yasuro; Sakamoto, NaoyaTri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis : a novel glycobiomarker for non-alcoholic steatohepatitis-Scientific reports-15-Jan-2020
Showing results 1 to 10 of 10

 

Hokkaido University